CLOZAPINE RECHALLENGE WITH LITHIUM AFTER DOUBLE INDUCED NEUTROPENIA: A CASE REPORT
Clozapine is a second generation antipsychotic drug, which has been acknowledged as the gold standard for treating both positive and negative symptoms of treatment-resistant schizophrenic patients, despite its severe side effects, such as neutropenia. Evidence suggest rechallenging after clozapine-i...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
InterOPTICS
2019-01-01
|
| Series: | Dialogues in Clinical Neuroscience & Mental Health |
| Subjects: | |
| Online Access: | http://www.obrela-journal.gr/index.php/obrela/article/view/103 |